Clinical management of potential bioterrorism-related conditions.
The agents most likely to be used in bioterrorism attacks are reviewed, along with the clinical syndromes they produce and their treatment.
Amesh A
AA
Adalja
Eric
E
Toner
Thomas V
TV
Inglesby
D000881:Anthrax / Q000175:diagnosis / Q000628:therapy; D001424:Bacterial Infections / Q000175:diagnosis* / Q000517:prevention & control / Q000628:therapy*; D023482:Bioterrorism; D001906:Botulism / Q000175:diagnosis / Q000628:therapy; D003937:Diagnosis, Differential; D006801:Humans; D010930:Plague / Q000175:diagnosis / Q000628:therapy; D012899:Smallpox / Q000175:diagnosis* / Q000628:therapy*; D014406:Tularemia / Q000175:diagnosis / Q000628:therapy; D014481:United States